The serum high-sensitive C reactive protein and homocysteine levels to evaluate the prognosis of acute ischemic stroke

Mediators of Inflammation

Volumn 2007, Issue , 2007, Pages

  Yoldas, Tahir ^a   Gonen, Murat ^a   Godekmerdan, Ahmet ^a   Ilhan, Fulya ^a   Bayram, Ednan ^b  

^a FIRAT UNIVERSITY   (Turkey)

^b Erzurum State Hospital   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; HOMOCYSTEINE;

AGED; ARTICLE; BLOOD ANALYSIS; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CLINICAL EVALUATION; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HEALTH STATUS; HOSPITAL ADMISSION; HUMAN; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; SCANDINAVIAN STROKE SCALE; STATISTICAL SIGNIFICANCE; ACUTE DISEASE; BLOOD; BRAIN ISCHEMIA; CASE CONTROL STUDY; METABOLISM; MIDDLE AGED; PATHOLOGY; STROKE; TIME;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; HOMOCYSTEINE; HUMANS; MIDDLE AGED; PROGNOSIS; STROKE; TIME FACTORS;

EID: 38749148798     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2007/15929     Document Type: Article

References (34)

1. J. A. Zivin Factors determining the therapeutic window for stroke. Neurology 50 3 1998 599 603
2. W.-D. Heiss A. Thiel M. Grond R. Graf Which targets are relevant for therapy of acute ischemic stroke? Stroke 30 7 1999 1486 1489
3. A. Furlan furlana@ccf.org R. Higashida L. Wechsler Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in acute cerebral thromboembolism. Journal of the American Medical Association 282 21 1999 2003 2011
4. S. M. Wolpert H. Bruckmann R. Greenlee L. Wechsler M. S. Pessin G. J. Del Zoppo Neuroradiologic evaluation of patients with acute stroke treated with recombinant tissue plasminogen activator. The rt-PA acute stroke study group. American Journal of Neuroradiology 14 1 1993 3 13
5. T. J. DeGraba The role of inflammation after acute stroke: utility of pursuing anti-adhesion molecule therapy. Neurology 51 3, supplement 1998 S62 S68
6. I. S. Ockene C. E. Matthews N. Rifai P. M. Ridker G. Reed E. Stanek Variability and classification accuracy of serial high-sensitivity C-reactive protein measurements in healthy adults. Clinical Chemistry 47 3 2001 444 450
7. P. M. Ridker High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 103 13 2001 1813 1818
8. N. Rifai P. M. Ridker High-sensitivity C-reactive protein: a novel and promising marker of coronary heart disease. Clinical Chemistry 47 3 2001 403 411
9. N. S. Rost P. A. Wolf C. S. Kase Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study. Stroke 32 11 2001 2575 2579
10. G. J. Blake P. M. Ridker Inflammatory bio-markers and cardiovascular risk prediction. Journal of Internal Medicine 252 4 2002 283 294
11. R. Ross rross@u.washington.edu Atherosclerosis - an inflammatory disease. New England Journal of Medicine 340 2 1999 115 126
12. V. Pasceri J. T. Willerson E. T. H. Yeh Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 102 18 2000 2165 2168
13. L. H. Kuller R. P. Tracy J. Shaten E. N. Meilahn Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention Trial. American Journal of Epidemiology 144 6 1996 537 547
14. R. S. Rosenson W. Koenig High-sensitivity C-reactive protein and cardiovascular risk in patients with coronary heart disease. Current Opinion in Cardiology 17 4 2002 325 331
15. P. M. Ridker pmridker@bics.bwh.harward.edu M. Cushman M. J. Stampfer R. P. Tracy C. H. Hennekens Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation 97 5 1998 425 428
16. P. M. Ridker pridker@partners.org S. S. Bassuk P. P. Toth C-reactive protein and risk of cardiovascular disease: evidence and clinical application. Current Atherosclerosis Reports 5 5 2003 341 349
17. G. Boysen gb01@bbh.hosp.dk T. Brander H. Christensen R. Gideon T. Truelsen Homocysteine and risk of recurrent stroke. Stroke 34 5 2003 1258 1261
18. J. Selhub P. F. Jacques A. G. Bostom Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. New England Journal of Medicine 332 5 1995 286 291
19. J. W. Eikelboom G. J. Hankey gjhankey@cyllene.uwa.edu.au S. S. Anand E. Lofthouse N. Staples R. I. Baker Association between high homocyst(e)ine and ischemic stroke due to large- and small-artery disease but not other etiologic subtypes of ischemic stroke. Stroke 31 5 2000 1069 1075
20. P. J. Kelly J. Rosand J. Kistler Homocysteine, MTHFR 677C→T polymorphism, and risk of ischemic stroke: results of a meta-analysis. Neurology 59 2002 529 536
21. C. J. Smith H. C. Emsley C. M. Gavin Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcome. BMC Neurology 4 1 2004 2
22. N. B. Beamer B. M. Coull W. M. Clark J. S. Hazel J. R. Silberger Interleukin-6 and interleukin-1 receptor antagonist in acute stroke. Annals of Neurology 37 6 1995 800 805
23. N. J. Rothwell J. K. Relton Involvement of cytokines in acute neurodegeneration in the CNS. Neuroscience and Biobehavioral Reviews 17 2 1993 217 227
24. M. Chopp R. L. Zhang H. Chen Y. Li N. Jiang J. R. Rusche Postischemic administration of an anti-Mac-1 antibody reduces ischemic cell damage after transient middle cerebral artery occlusion in rats. Stroke 25 4 1994 869 875
25. N. Jiang M. Moyle H. R. Soule W. E. Rote M. Chopp Neutrophil inhibitory factor is neuroprotective after focal ischemia in rats. Annals of Neurology 38 6 1995 935 942
26. K. W. Muir k.muir@clinmed.gla.ac.uk C. J. Weir W. Alwan I. B. Squire K. R. Lees C-reactive protein and outcome after ischemic stroke. Stroke 30 5 1999 981 985
27. M. Di Napoli F. Papa V. Bocola C-reactive protein in ischemic stroke: an independent prognostic factor. Stroke 32 4 2001 917 924
28. J. C. Chambers A. McGregor J. Jean-Marie O. A. Obeid J. S. Kooner jkooner@rpms.ac.uk Demonstration of rapid onset vascular endothelial dysfunction after hyperhomocysteinemia: an effect reversible with vitamin C therapy. Circulation 99 9 1999 1156 1160
29. F. Nappo N. De Rosa R. Marfella Impairment of endothelial functions by acute hyperhomocysteinemia and reversal by antioxidant vitamins. Journal of the American Medical Association 281 22 1999 2113 2118
30. J.-H. Yoo drjhyoo@smc.samsung.co.kr C.-S. Chung S.-S. Kang Relation of plasma homocyst(e)ine to cerebral infarction and cerebral atherosclerosis. Stroke 29 12 1998 2478 2483
31. D. J. Meiklejohn M. A. Vickers R. Dijkhuisen M. Greaves Plasma homocysteine concentrations in the acute and convalescent periods of atherothrombotic stroke. Stroke 32 1 2001 57 62
32. A. Lindgren L. Brattstrom B. Norrving B. Hultberg A. Andersson B. B. Johansson Plasma homocysteine in the acute and convalescent phases after stroke. Stroke 26 5 1995 795 800
33. M. Ribó marcriboj@hotmail.com J. Montaner J. Monasterio Role of homocysteine in the acute phase of stroke. Neurologia 19 1 2004 10 14
34. J. Pniewski pniewski@cmdik.pan.pl M. Chodakowska-Zebrowska R. Woźniak K. Stȩpień A. Stafiej Plasma homocysteine level and the course of ischemic stroke. Acta Neurobiologiae Experimentalis 63 2 2003 127 130